Florence Thibaut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Florence Thibaut has a total of 562 co-authors. Here are the top co-authors by number of shared publications:
- Leo Malandain
Department of Psychiatry-Addictology, University Hospital Cochin (Hospital Tarnier, AP-HP), Paris, France
6 shared publications - Frederico Duarte Garcia
Universidade Federal de Minas Gerais
4 shared publications - Sandrine Lamy
INSERM U1266, Institute of Psychiatry and Neurosciences, Paris, France
4 shared publications - Alessandro Serretti
Department of Medicine and Surgery, Kore University of Enna, Enna, Italy
3 shared publications - Carla Gallo
Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima 15102, Perú
3 shared publications - Dan Rujescu
Department of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria
3 shared publications
Latest Publications
- Open Access
Co-expression-based models improve eQTL predictions and highlight novel transcriptome-wide genes associated with schizophrenia
Non-coding genetic variants statistically associated with complex heritability phenotypes are thought to act primarily through transcriptome regulatory mechanisms. Predictions of gene expression in tissue like the human brain traditionally rely primarily on cis -eQTLs. Here, we introduce INGENE and MODULE, trans -eQTLs models designed to enhance the prediction of gene expression by capturing the collective impact of candidate trans -eQTLs acting within co-expression networks. Exploiting RNA-seq data in six post-mortem brain regions (amygdala, caudate nucleus, dorsal/subgenual anterior cingulate cortex, dorsolateral prefrontal cortex, and hippocampus), we validate our models on two testing datasets, demonstrating increased gene predictability compared to both an original cis -based model and to EpiXcan, the leading benchmark in cis -model performance. Integration of cis - and trans -predictions significantly improves gene-level expression imputation (MLE α= 0.05) for 18,744 genes across the six brain regions considered. Applying cis and trans models to PGC wave 3 genotypes identifies 766 SCZ-associated genes across brain regions (pFDR < .01), emphasizing the complementary nature of cis and trans predictions in trait association discovery. Of these genes, 641 represent novel transcriptome-wide associations with schizophrenia, highlighting the role of trans -heritability and genetic interactions underlying risk for this disorder, in addition to further supporting 125 previous candidates.
Open AccessCo-expression-based models improve eQTL predictions and highlight novel transcriptome-wide genes associated with schizophrenia
Non-coding genetic variants statistically associated with complex heritability phenotypes are thought to act primarily through transcriptome regulatory mechanisms. Predictions of gene expression in tissue like the human brain traditionally rely primarily on cis -eQTLs. Here, we introduce INGENE and MODULE, trans -eQTLs models designed to enhance the prediction of gene expression by capturing the collective impact of candidate trans -eQTLs acting within co-expression networks. Exploiting RNA-seq data in six post-mortem brain regions (amygdala, caudate nucleus, dorsal/subgenual anterior cingulate cortex, dorsolateral prefrontal cortex, and hippocampus), we validate our models on two testing datasets, demonstrating increased gene predictability compared to both an original cis -based model and to EpiXcan, the leading benchmark in cis -model performance. Integration of cis - and trans -predictions significantly improves gene-level expression imputation (MLE α= 0.05) for 18,744 genes across the six brain regions considered. Applying cis and trans models to PGC wave 3 genotypes identifies 766 SCZ-associated genes across brain regions (pFDR < .01), emphasizing the complementary nature of cis and trans predictions in trait association discovery. Of these genes, 641 represent novel transcriptome-wide associations with schizophrenia, highlighting the role of trans -heritability and genetic interactions underlying risk for this disorder, in addition to further supporting 125 previous candidates.
- Open Access
- 7 January 2026
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 29 (1) , 8
Gender and income disparities in World Psychiatry Congress participation (2023–2024)
Purpose: Although the number of women in psychiatry has increased substantially, gender disparities remain in leadership and visibility at scientific meetings. Country income level also affects academic participation, but its impact within the field of psychiatry remains underinvestigated. This study examined gender and income disparities at the country level, as well as gender and income disparities within countries, at two consecutive World Congresses of Psychiatry (WCPs), held in Austria (2023) and Mexico (2024). Methods: The scientific programs of WCP 2023 and WCP 2024 were systematically reviewed to identify all speakers and chairs. Data were extracted on gender, role, session type, and country income level, classified according to World Bank criteria. Gender was determined from congress profiles, photographs, pronouns, or the Gender API. Statistical analyses included chi-square tests with Bonferroni corrections, with significance set at p < 0.05. Results: WCP 2023 featured 999 speakers/chairs, and WCP 2024 featured 574. Women’s representation increased significantly from 37.4% in 2023 to 43.4% in 2024 ( χ² = 5.382, df = 1, p = 0.020). Participation from low- and middle-income countries also rose in 2024, while men’s representation from high-income countries declined. Several session types in 2024 reached or exceeded gender parity, including Distinguished Lectures (58.3%), Panel Discussions (50%), and Early Career Psychiatrist Sessions (60%). Conclusions: Women’s representation at WCPs has shown encouraging improvement, although parity has not yet been achieved, and differences are evident by country income level. Hosting congresses in middle-income countries may support broader participation. Continued monitoring, mentorship initiatives, and inclusive conference policies can further strengthen gender equality and global representation in psychiatry.
- 7 January 2026
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 29 (1) , 8
Open AccessGender and income disparities in World Psychiatry Congress participation (2023–2024)
Purpose: Although the number of women in psychiatry has increased substantially, gender disparities remain in leadership and visibility at scientific meetings. Country income level also affects academic participation, but its impact within the field of psychiatry remains underinvestigated. This study examined gender and income disparities at the country level, as well as gender and income disparities within countries, at two consecutive World Congresses of Psychiatry (WCPs), held in Austria (2023) and Mexico (2024). Methods: The scientific programs of WCP 2023 and WCP 2024 were systematically reviewed to identify all speakers and chairs. Data were extracted on gender, role, session type, and country income level, classified according to World Bank criteria. Gender was determined from congress profiles, photographs, pronouns, or the Gender API. Statistical analyses included chi-square tests with Bonferroni corrections, with significance set at p < 0.05. Results: WCP 2023 featured 999 speakers/chairs, and WCP 2024 featured 574. Women’s representation increased significantly from 37.4% in 2023 to 43.4% in 2024 ( χ² = 5.382, df = 1, p = 0.020). Participation from low- and middle-income countries also rose in 2024, while men’s representation from high-income countries declined. Several session types in 2024 reached or exceeded gender parity, including Distinguished Lectures (58.3%), Panel Discussions (50%), and Early Career Psychiatrist Sessions (60%). Conclusions: Women’s representation at WCPs has shown encouraging improvement, although parity has not yet been achieved, and differences are evident by country income level. Hosting congresses in middle-income countries may support broader participation. Continued monitoring, mentorship initiatives, and inclusive conference policies can further strengthen gender equality and global representation in psychiatry.
- Open Access
Psychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effects
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.
Open AccessPsychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effects
Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.
- Open Access
- 10 May 2025
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 27 (1) , 112-128
5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders
Despite the relatively limited number of serotonergic neurons in humans, serotonin plays a key role in neurophysiological functions, including sleep, pain perception, learning, memory, cognition, emotion, reward, and mood regulation. Altered serotonergic neurotransmission is linked to conditions such as anxiety, depression, anorexia, migraine, insomnia, schizophrenia, Alzheimer's disease (AD), and cognitive impairments. The 5-HT6 receptor (5-HT6R), mainly found in brain regions involved in cognition, is a promising therapeutic target for cognitive deficits in neuropsychiatric disorders, particularly AD and schizophrenia. Preclinical studies have shown that 5-HT6R antagonists improve cognitive function. 5-HT6R interacts dynamically with an extensive intracellular protein network, regulating the localisation, trafficking, and signalling of these proteins. Proteomic and genetic studies have revealed interactions with mTOR kinase and neurofibromin, both of which are crucial for synaptic plasticity, learning, and memory. Fyn kinase is also associated with 5-HT6Rs, reinforcing receptor expression and G-protein coupling. Notably, the G protein-regulated inducer of neurite outgrowth 1 (GPRIN1) interacts with 5-HT6Rs independently of agonists, enhancing receptor activity. This review highlights the clinical testing of 5-HT6R ligands as regulators of these complex signalling properties, underscoring their therapeutic potential in addressing cognitive impairments associated with neuropsychiatric disorders.
- 10 May 2025
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 27 (1) , 112-128
Open Access5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders
Despite the relatively limited number of serotonergic neurons in humans, serotonin plays a key role in neurophysiological functions, including sleep, pain perception, learning, memory, cognition, emotion, reward, and mood regulation. Altered serotonergic neurotransmission is linked to conditions such as anxiety, depression, anorexia, migraine, insomnia, schizophrenia, Alzheimer's disease (AD), and cognitive impairments. The 5-HT6 receptor (5-HT6R), mainly found in brain regions involved in cognition, is a promising therapeutic target for cognitive deficits in neuropsychiatric disorders, particularly AD and schizophrenia. Preclinical studies have shown that 5-HT6R antagonists improve cognitive function. 5-HT6R interacts dynamically with an extensive intracellular protein network, regulating the localisation, trafficking, and signalling of these proteins. Proteomic and genetic studies have revealed interactions with mTOR kinase and neurofibromin, both of which are crucial for synaptic plasticity, learning, and memory. Fyn kinase is also associated with 5-HT6Rs, reinforcing receptor expression and G-protein coupling. Notably, the G protein-regulated inducer of neurite outgrowth 1 (GPRIN1) interacts with 5-HT6Rs independently of agonists, enhancing receptor activity. This review highlights the clinical testing of 5-HT6R ligands as regulators of these complex signalling properties, underscoring their therapeutic potential in addressing cognitive impairments associated with neuropsychiatric disorders.
- 20 January 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-6
Chemsex and Digital Relationships: Virtual Pleasure, Real Danger
- 20 January 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-6
Chemsex and Digital Relationships: Virtual Pleasure, Real Danger
- Open Access
- 22 November 2024
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 26 (1) , 77-88
A profile of French clergymen who sexually assaulted victims and a review
Sexual abuse within the Catholic Church is a distressing concern. As part of the investigation conducted by the French Independent Commission on Sexual Abuse in the Church, we analysed available files of convicted sexual abusers between 1950 and 2020. We analysed the socio-demographic and clinical characteristics of French clergymen sex offenders. Thirty-five clergymen were included. Sexual assaults were documented for 176 individuals in total, including 153 minors (79.7% male) and 23 adults (52.2% female). No sex offender assaulted both juvenile and adult victims. Homosexuality was declared in 50% of the perpetrators. A past history of child sexual abuse was observed in 30% (N = 9) of juvenile offenders. The mean number of victims per offender was around 5, with the highest mean number in male or both sex juvenile offenders. More than 90% of the victims were known to the perpetrator. Both hands-on and hands-off sexual offences occurred in over 80% of male juvenile offenders compared to less than 6% of female juvenile offenders and less than 17% of adult offenders. Sex offenders within the Catholic Church present some specificities in comparison to non religious sex offenders, such as a higher number of male juvenile victims somewhat older and more often known. Personal, interpersonal and systemic factors, some of which being specific, interact to foster sexual offence. Prevention of sexual abuse within the Catholic Church is crucial.
- 22 November 2024
- Published by Taylor & Francis in Dialogues in clinical neuroscience
- Vol. 26 (1) , 77-88
Open AccessA profile of French clergymen who sexually assaulted victims and a review
Sexual abuse within the Catholic Church is a distressing concern. As part of the investigation conducted by the French Independent Commission on Sexual Abuse in the Church, we analysed available files of convicted sexual abusers between 1950 and 2020. We analysed the socio-demographic and clinical characteristics of French clergymen sex offenders. Thirty-five clergymen were included. Sexual assaults were documented for 176 individuals in total, including 153 minors (79.7% male) and 23 adults (52.2% female). No sex offender assaulted both juvenile and adult victims. Homosexuality was declared in 50% of the perpetrators. A past history of child sexual abuse was observed in 30% (N = 9) of juvenile offenders. The mean number of victims per offender was around 5, with the highest mean number in male or both sex juvenile offenders. More than 90% of the victims were known to the perpetrator. Both hands-on and hands-off sexual offences occurred in over 80% of male juvenile offenders compared to less than 6% of female juvenile offenders and less than 17% of adult offenders. Sex offenders within the Catholic Church present some specificities in comparison to non religious sex offenders, such as a higher number of male juvenile victims somewhat older and more often known. Personal, interpersonal and systemic factors, some of which being specific, interact to foster sexual offence. Prevention of sexual abuse within the Catholic Church is crucial.
- 24 May 2023
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (3) , 563-571
Chemsex: review of the current literature and treatment guidelines
- 24 May 2023
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (3) , 563-571
Chemsex: review of the current literature and treatment guidelines
- 18 April 2023
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 46 (3) , 415-426
Women's Mental Health and Lessons Learnt from the COVID-19 Pandemic
- 18 April 2023
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 46 (3) , 415-426
Women's Mental Health and Lessons Learnt from the COVID-19 Pandemic
- Open Access
- 10 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2175
Perinatal Psychoactive Substances Use: A Rising Perinatal Mental Health Concern
Introduction: A significant increase in psychoactive drugs use was observed in women of childbearing age and during the perinatal period worldwide. Yet, the use of illicit drugs, alcohol and tobacco during pregnancy is a serious health risk for the mother, developing fetus and newborn. Methods: This review of current trends and consequences of psychoactive substance use in the general population and in pregnant women was conducted using the English and French literature published during the years 2000 to 2022, supplemented by guidelines, meta-analyses and reviews. Results: According to current rates of prenatal substances use, it was calculated that 380,000 offspring were exposed to illicit substances, more than 500,000 to alcohol and over one million to tobacco during uterine life. Alarmingly, drug-related pregnancy-associated mortality has shown a staggering 190% rise between 2010 and 2019 in the USA. Different drugs of abuse, when used during pregnancy, increase the risk of stillbirth, neonatal abstinence syndrome and sudden infant death. Adverse effects on pregnancy include premature rupture of membranes, placental abruption, preterm birth, low birth space? weight and small-for-gestational-age infants. There is also an increased risk of morbidity and mortality for the pregnant women. Long-term negative adverse effects of perinatal exposure to substances also include a number of neurocognitive, behavioral and emotional dysfunctions in infants. Each type of substance has its own specificities, which will be briefly summarized. Conclusion: All childbearing age women must be informed about the potential harm of the prenatal use of psychoactive substances and should be encouraged to stop their use when pregnancy is planned and, at least, when pregnancy is known. Questioning women about their alcohol consumption should be systematic at the first prenatal visit and then at every prenatal visit until delivery. Multidisciplinary prevention approaches as well as intervention measures targeted to each type of psychoactive substance can save mothers’ lives and mitigate serious adversities to the offspring.
- 10 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2175
Open AccessPerinatal Psychoactive Substances Use: A Rising Perinatal Mental Health Concern
Introduction: A significant increase in psychoactive drugs use was observed in women of childbearing age and during the perinatal period worldwide. Yet, the use of illicit drugs, alcohol and tobacco during pregnancy is a serious health risk for the mother, developing fetus and newborn. Methods: This review of current trends and consequences of psychoactive substance use in the general population and in pregnant women was conducted using the English and French literature published during the years 2000 to 2022, supplemented by guidelines, meta-analyses and reviews. Results: According to current rates of prenatal substances use, it was calculated that 380,000 offspring were exposed to illicit substances, more than 500,000 to alcohol and over one million to tobacco during uterine life. Alarmingly, drug-related pregnancy-associated mortality has shown a staggering 190% rise between 2010 and 2019 in the USA. Different drugs of abuse, when used during pregnancy, increase the risk of stillbirth, neonatal abstinence syndrome and sudden infant death. Adverse effects on pregnancy include premature rupture of membranes, placental abruption, preterm birth, low birth space? weight and small-for-gestational-age infants. There is also an increased risk of morbidity and mortality for the pregnant women. Long-term negative adverse effects of perinatal exposure to substances also include a number of neurocognitive, behavioral and emotional dysfunctions in infants. Each type of substance has its own specificities, which will be briefly summarized. Conclusion: All childbearing age women must be informed about the potential harm of the prenatal use of psychoactive substances and should be encouraged to stop their use when pregnancy is planned and, at least, when pregnancy is known. Questioning women about their alcohol consumption should be systematic at the first prenatal visit and then at every prenatal visit until delivery. Multidisciplinary prevention approaches as well as intervention measures targeted to each type of psychoactive substance can save mothers’ lives and mitigate serious adversities to the offspring.
- 29 December 2022
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (1) , 52-59
Pharmacological Treatments for Compulsive Sexual Behaviors Among Offending Individuals
- 29 December 2022
- Published by Springer Nature in Current Addiction Reports
- Vol. 10 (1) , 52-59
Pharmacological Treatments for Compulsive Sexual Behaviors Among Offending Individuals